Cleared Traditional

AMERLITE TSH ASSAY, LAN.0001/2001 240 & 144 KIT (K882907) - FDA 510(k) Clearance

Class II Chemistry device cleared through predicate-based substantial equivalence - typically does not require clinical trials.

K882907 · Amersham Corp. · Chemistry device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Sep 1988
Decision
72d
Days
Class 2
Risk

K882907 is an FDA 510(k) clearance for the AMERLITE TSH ASSAY, LAN.0001/2001 240 & 144 KIT. Classified as Radioimmunoassay, Thyroid-stimulating Hormone (product code JLW), Class II - Special Controls.

Submitted by Amersham Corp. (Arlington Heights, US). The FDA issued a Cleared decision on September 22, 1988 after a review of 72 days - a notably fast clearance cycle.

This device falls under the Chemistry FDA review panel, regulated under 21 CFR 862.1690 - the FDA in vitro diagnostics and chemistry framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Fast-track predicate clearance. Standard predicate reliance. The short review cycle indicates strong predicate alignment - the FDA found sufficient equivalence without extended technical review.

View all Amersham Corp. devices

Submission Details

510(k) Number K882907 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received July 12, 1988
Decision Date September 22, 1988
Days to Decision 72 days
Submission Type Traditional
Review Panel Chemistry (CH)
Summary -
Third-party Review No - reviewed directly by FDA
Regulatory Context
Review time vs. panel average
16d faster than avg
Panel avg: 88d · This submission: 72d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

Device Classification

Product Code JLW Radioimmunoassay, Thyroid-stimulating Hormone
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 862.1690
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Chemistry devices follow this clearance model.

Regulatory Peers - JLW Radioimmunoassay, Thyroid-stimulating Hormone

All 70
Devices cleared under the same product code (JLW) and FDA review panel - the closest regulatory comparables to K882907.
AFFINITY(TM) HTSH(TM)
K897138 · Bd Becton Dickinson Vacutainer Systems Preanalytic · Mar 1990
MILENIA (TM) TSH
K900014 · Diagnostic Products Corp. · Jan 1990
COTUBE(TM) TSH IRMA
K890802 · Bio-Rad · Mar 1989
ABBOTT IMX HTSH
K880086 · Abbott Laboratories · Apr 1988
IRMA-COUNT TSH RKTS1, RKTS2, RKTS5, RKTSX
K872305 · Diagnostic Products Corp. · Jul 1987
IQ TSH IMMUNOASSAY
K870244 · Bd Becton Dickinson Vacutainer Systems Preanalytic · Apr 1987